The combination of the two drugs shows very promising results in the treatment of neuroblastoma, a rare but serious cancer that mainly affects infants and young children. Researchers from Ghent University have discovered this. The key to the new treatment lies with an existing drug, Triapine.
ttn-3
Combination of two drugs seems very promising against childhood cancer, UGent researchers discover
